4:12am PDT - October 13th, 2021

RT @LogycThaLion: $JNJ Johnson & Johnson's Janssen reports new subgroup analysis of the Phase 3 OPTIMUM study demonstrates the benefits of…

0 retweets   1 likes  - Joe Gambiste (@Gambiste1)